Back to All Events

Panel: Partnering in the rare disease space - industry perspectives

Very pleased to announce I will be on an industry panel (with some much bigger companies) and pitching at the upcoming World Orphan Drug Congress in Boston April 23-25. I look forward to seeing you there!

Kathie Bishop, SVP, Head of Rare Disease and External Innovation, Acadia Pharmaceuticals Inc.
Shira Landskroner-Eiger, Director, External Innovation Rare Disease, IPSEN
Sean Ekins, CEO and Founder, Collaborations Pharmaceuticals, Inc

Find out more and register here https://lnkd.in/ewRjEeNU

Previous
Previous
April 1

AI/ML for Early Drug Discovery Conference

Next
Next
July 11

The Dark Side of AI: Dual Use of AI-powered Drug Discovery